Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Fidelity Disruptive Medicine ETF (FMED) belongs to the Multiple Trends segment. Goldman Sachs Future Health Care Equity ETF (GDOC) is part of the Healthcare Technology segment. Both ETFs have the same top 3 sector exposures: and Health Care. FMED is less expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.75% for GDOC. FMED is down -10.31% year-to-date (YTD) with - in YTD flows. GDOC performs better with -8.56% YTD performance, and +$2M in YTD flows. Run a side-by-side ETF comparison of FMED and GDOC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FMED GDOC | -6.92%-5.86% | -10.09%-7.97% | -10.31%-8.56% | -0.32%+0.06% | n/a+6.20% | n/an/a |
| Flows | FMED GDOC | -+$2M | -+$2M | -+$2M | +$5M+$920K | --$77M | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FMED GDOC | +19.28%+13.81% | +19.99%+16.35% | n/a+14.13% | n/an/a |
| Max drawdown | FMED GDOC | -14.72%-11.93% | -15.97%-12.56% | n/a-22.18% | n/an/a |
| Max drawdown duration | FMED GDOC | 55d69d | 108d110d | n/a449d | n/an/a |
FMED | GDOC | |
Last sale 3/18/2026 at 1:30 PM | $24.30 | $32.12 |
| Previous close 03/18/2026 | $24.77 | $32.52 |
| Consolidated volume 03/18/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
FMED | GDOC | |
|---|---|---|
| Last price | $24.30 | $32.12 |
| 1D performance | -1.91% | -1.25% |
| AuM | $56.47 M | $21.17 M |
| E/R | 0.5% | 0.75% |
FMED | GDOC | |
|---|---|---|
| Management strategy | Active | Active |
| Provider | Fidelity | Goldman Sachs |
| Benchmark | - | - |
| N° of holdings | 50 | 35 |
| Asset class | - | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 12, 2023 | November 11, 2021 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
